- A new machine learning model has been developed to identify new risk genes for motor neurone disease
- The model has so far identified 690 risk genes for MND, many of which are new discoveries
- The findings could pave the way for new targeted therapeutics and genetic testing for the disease
Scientists have developed a new machine learning model for the discovery of genetic risk factors for diseases such as Motor Neurone Disease (MND).
Designed by researchers from the University of Sheffield and the Stanford University School of Medicine in the US, the machine learning tool, named RefMap, has already been utilised by the team to discover 690 risk genes for motor neurone disease, many of which are new discoveries.
One of the genes highlighted as a new MND gene, called KANK1, has been shown by the team to produce neurotoxicity in human neurons very similar to that observed in the brains of patients. Although at an early stage, this is potentially a new target for the design of new drugs.
Dr Johnathan Cooper-Knock, from the University of Sheffield’s Neuroscience Institute, said: “This new tool will help us to understand and profile the genetic basis of MND. Using this model we have already seen a dramatic increase in the number of risk genes for MND, from approximately 15 to 690.
“Each new risk gene discovered is a potential target for the development of new treatments for MND and could also pave the way for genetic testing for families to work out their risk of disease.”
The 690 new genes identified by RefMap lead to a five-fold increase in discovered heritability, a measure which describes how much of the disease is due to a variation in genetic factors.
“RefMap identifies risk genes by integrating genetic and epigenetic data. It is a generic tool and we are applying it to more diseases in the lab,” Sai Zhang, PhD, instructor of genetics at the Stanford University School of Medicine said.
Michael Snyder, PhD, professor and chair of the department of genetics at the Stanford School of Medicine and also the corresponding author of this work added: “By doing machine learning for genome analysis, we are discovering more hidden genes for human complex diseases such as MND, which will eventually power personalised treatment and intervention.”
For further information please contact: Emma Griffiths, Junior Media and PR Officer, University of Sheffield, 0114 222 1034, firstname.lastname@example.org
Notes to editors
The University of Sheffield
The University of Sheffield is one of the world's top 100 universities, renowned for the excellence, impact and distinctiveness of its research-led learning and teaching.
As a member of the UK’s prestigious Russell Group, almost 30,000 of the brightest students from over 140 countries, learn alongside some of the best academics from across the globe.
Sheffield’s outstanding performance for excellent teaching and research is consistently confirmed by international independent assessments. Renowned for its student experience, Sheffield’s Students’ Union is regularly voted as the best in the UK.
The University’s life enhancing research, innovation and education not only transforms the lives of its graduates, but shapes the world we live in. In the most recent UK Research Excellence Framework, 86 percent of Sheffield’s research was assessed as world-leading or internationally excellent.
With six Nobel Prize winners among its former staff and students, Sheffield has a proud history of discovery, innovation and social change. In 1930, it pioneered the very first medical use of penicillin, while more recently researchers developed a lifesaving drug for the treatment of ovarian and breast cancer.
Today, it’s pioneering research into sustainable farming to safeguard the world’s food supply, recreating the interiors of the Chernobyl and Fukushima nuclear reactors to aid the clean-up process, and working with the world’s biggest social media companies to protect vulnerable users from harmful content.
Focussed on equipping students for life after Sheffield, the outstanding research-led teaching is empowering the next generation of global citizens.
Genome-wide identification of the genetic basis of amyotrophic lateral sclerosis